Sunday, December 22, 2024

Canada’s Politics and Government News Source Since 1989

Sunday, December 22, 2024 | Latest Paper

Peter N. Lewis and Jeremy Hirota

Peter N. Lewis is professor emeritus of biochemistry at the University of Toronto, board chair of the Charles H. Best Foundation, and CEO and co-founder of Rosetta Therapeutics. Jeremy Hirota is an assistant professor in the department of medicine at McMaster University, Canada Research Chair Respiratory Mucosal Immunology and CEO and co-founder of Infinotype.

Canada can’t afford to leave research out of the innovation conversation

Over the course of Canada’s late summer election, it was promising to see innovation featured on the agenda of our federal leaders as action

Opinion | BY PETER N. LEWIS AND JEREMY HIROTA | December 28, 2021

Canada can’t afford to leave research out of the innovation conversation

Opinion | BY PETER N. LEWIS AND JEREMY HIROTA | December 28, 2021

Over the course of Canada’s late summer election, it was promising to see innovation featured on the agenda of our federal leaders as action

Canada can’t afford to leave research out of the innovation conversation

Opinion | BY PETER N. LEWIS AND JEREMY HIROTA | December 28, 2021

Over the course of Canada’s late summer election, it was promising to see innovation featured on the agenda of our federal leaders as action